Verstovsek, S <br/><br/>
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.  [electronic resource] 

 -  Leukemia  Aug 2001 
 - 1165-70 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2402182  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Biomarkers, Tumor<br/>Hepatocyte Growth Factor--blood<br/>Humans<br/>Leukemia, Myeloid--blood<br/>Middle Aged<br/>Myelodysplastic Syndromes--blood<br/>Predictive Value of Tests<br/>Prognosis<br/>Survival Analysis